MedPath

Determination of antibiotic concentrations in interstitial space fluid of muscle and subcutis in septic patients including a pilot phase

Conditions
A41.9
Sepsis, unspecified
Registration Number
DRKS00005046
Lead Sponsor
Knappschaftskrankenhaus BochumKlinik für Anästhesiologie, Intensivmedizin und Schmerztherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Severe sepsis or septic shock as diagnosed according to the criteria of ACCP/SCCM and the MAXSEP Study within 24 hours:

Exclusion Criteria

Age < 18 years

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the concentration time curve (AUC), maximum concentration (Cmax), half-life (t1/2) in the microdialysate and plasma after single dose and at steady state.<br>
Secondary Outcome Measures
NameTimeMethod
Assoziation of 30 days survival in patients withe sepsis dependent on tussues concentrations of antibiotics. Plasma will be revieled with microdialysis and analysed with HPLC.
© Copyright 2025. All Rights Reserved by MedPath